ketoconazole for Cushing
Selected indexed studies
- Ketoconazole as second-line treatment for Cushing's disease after transsphenoidal surgery: systematic review and meta-analysis. (Front Endocrinol (Lausanne), 2023) [PMID:37223017]
- Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort. (Front Endocrinol (Lausanne), 2022) [PMID:36277689]
- The Treatment of Cushing's Disease. (Endocr Rev, 2015) [PMID:26067718]
_Worker-drafted node — pending editorial review._
Connections
ketoconazole for Cushing is a side effect of
Sources
- Diagnosis and Treatment of Pituitary Adenomas: A Review. (2017) pubmed
- Ketoconazole as second-line treatment for Cushing's disease after transsphenoidal surgery: systematic review and meta-analysis. (2023) pubmed
- Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort. (2022) pubmed
- The Treatment of Cushing's Disease. (2015) pubmed
- Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome. (2026) pubmed
- Cushing's syndrome. (1989) pubmed
- Osilodrostat (Isturisa) for Cushing's disease. (2021) pubmed
- Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment. (2021) pubmed
- Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs). (2025) pubmed
- Adrenally Directed Medical Therapies for Cushing Syndrome. (2021) pubmed